Laddar...
Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients
Pancreatic cancer remains a lethal disease that responds poorly to multiple types of treatment. Therefore, the identification of distinct subgroups that exhibit unique therapeutic responses is an urgent requirement. In the present multicenter study (1,912 cases), the differences between the therapeu...
Sparad:
| I publikationen: | Oncol Lett |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
D.A. Spandidos
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351346/ https://ncbi.nlm.nih.gov/pubmed/28356973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5501 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|